Latest Breaking News On - ப்ரிடிக்டிவ் புற்றுநோயியல் இன்க் - Page 2 : comparemela.com

30 Stocks Moving in Friday s Pre-Market Session Benzinga 3 hrs ago Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and commercialize gedatolisib. The company also reported preliminary data from Phase 1b Trial of gedatolisib plus ibrance and endocrine therapy for patients with ER+/HER2- metastatic breast cancer. Gulf Resources, Inc. (NASDAQ: GURE) rose 29.5% to $6.02 in pre-market trading after the company reported a narrower loss for the fourth quarter. TherapeuticsMD, Inc. (NASDAQ: TXMD) rose 19% to $1.57 in pre-market trading after the company, and Theramex, announced the approval of BIJUVE capsules indicated for hormone replacement therapy in the U.K. and under the trade name BIJUVA in Belgium.

United statesColumbia university irving medical centerEducation group international limitedAmerican football confederationTv incNaked brand group limitedSunworks incAdvaxis incUv incShandong university of art designOutdoors incJpmorgan chase coGreenwich lifesciences incHumanigen incGainerscelcuity incPredictive oncology inc